Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

NCT02711176 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Infection

Interventions

DRUG: Nexium
DRUG: Tinafas
DRUG: Tavanex
DRUG: Lanzol
DRUG: Klacid
DRUG: Iramox

Sponsor

Zahra Vahdat Shariatpanahi